These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12668670)

  • 1. Broadly distributed chemical reactivity of natural antibodies expressed in coordination with specific antigen binding activity.
    Planque S; Taguchi H; Burr G; Bhatia G; Karle S; Zhou YX; Nishiyama Y; Paul S
    J Biol Chem; 2003 May; 278(22):20436-43. PubMed ID: 12668670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific HIV gp120-cleaving antibodies induced by covalently reactive analog of gp120.
    Paul S; Planque S; Zhou YX; Taguchi H; Bhatia G; Karle S; Hanson C; Nishiyama Y
    J Biol Chem; 2003 May; 278(22):20429-35. PubMed ID: 12665517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.
    Paul S; Karle S; Planque S; Taguchi H; Salas M; Nishiyama Y; Handy B; Hunter R; Edmundson A; Hanson C
    J Biol Chem; 2004 Sep; 279(38):39611-9. PubMed ID: 15269209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontogeny of proteolytic immunity: IgM serine proteases.
    Planque S; Bangale Y; Song XT; Karle S; Taguchi H; Poindexter B; Bick R; Edmundson A; Nishiyama Y; Paul S
    J Biol Chem; 2004 Apr; 279(14):14024-32. PubMed ID: 14726510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for immunotherapeutic proteolytic antibodies.
    Zhou YX; Karle S; Taguchi H; Planque S; Nishiyama Y; Paul S
    J Immunol Methods; 2002 Nov; 269(1-2):257-68. PubMed ID: 12379366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity.
    Nishiyama Y; Mitsuda Y; Taguchi H; Planque S; Hara M; Karle S; Hanson CV; Uda T; Paul S
    J Mol Recognit; 2005; 18(4):295-306. PubMed ID: 15706608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphonate ester probes for proteolytic antibodies.
    Paul S; Tramontano A; Gololobov G; Zhou YX; Taguchi H; Karle S; Nishiyama Y; Planque S; George S
    J Biol Chem; 2001 Jul; 276(30):28314-20. PubMed ID: 11346653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit.
    Nishiyama Y; Karle S; Planque S; Taguchi H; Paul S
    Mol Immunol; 2007 Apr; 44(10):2707-18. PubMed ID: 17222909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism-based probe for gp120-Hydrolyzing antibodies.
    Taguchi H; Burr G; Karle S; Planque S; Zhou YX; Paul S; Nishiyama Y
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3167-70. PubMed ID: 12372525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.
    Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR
    Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs.
    Nishiyama Y; Taguchi H; Luo JQ; Zhou YX; Burr G; Karle S; Paul S
    Arch Biochem Biophys; 2002 Jun; 402(2):281-8. PubMed ID: 12051675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
    Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
    Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120.
    Boudet F; Girard M; Theze J; Zouali M
    Int Immunol; 1992 Feb; 4(2):283-94. PubMed ID: 1377948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
    Nakamura GR; Byrn R; Wilkes DM; Fox JA; Hobbs MR; Hastings R; Wessling HC; Norcross MA; Fendly BM; Berman PW
    J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on affinity constants of hapten-specific monoclonal antibodies using an antibody-immobilized ELISA.
    Chu KS; Jin S; Guo J; Jue M; Huang JJ
    Biotechnol Prog; 1995; 11(3):352-6. PubMed ID: 7619405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.